Luminescence complementation technology for the identification of MYC:TRRAP inhibitors

Mechanism-based targeted therapies have exhibited remarkable success in treating otherwise untreatable or unresectable cancers. Novel targeted therapies that correct dysregulated transcriptional programs in cancer are an unmet medical need. The transcription factor MYC is the most frequently amplifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feris, Edmond J., Hinds, John W., Cole, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522838/
https://www.ncbi.nlm.nih.gov/pubmed/34676047
http://dx.doi.org/10.18632/oncotarget.28078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522838/
https://www.ncbi.nlm.nih.gov/pubmed/34676047
http://dx.doi.org/10.18632/oncotarget.28078

Ejemplares similares